IL-15 in the life and death of lymphocytes: immunotherapeutic implications.
Waldmann
Thomas A
TA
Metabolism Branch, Center for Cancer Research, National Cancer Institute/National Institutes of Health, Bethesda, MD 20892-1374, USA. tawald@helix.nih.gov
D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy; D000818:Animals; D000911:Antibodies, Monoclonal / Q000737:chemistry; D001327:Autoimmune Diseases; D018414:CD8-Positive T-Lymphocytes / Q000378:metabolism; D019496:Cancer Vaccines; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D019409:Interleukin-15 / Q000096:biosynthesis* / Q000502:physiology*; D007376:Interleukin-2 / Q000502:physiology; D008954:Models, Biological; D009369:Neoplasms / Q000628:therapy; D053647:Receptors, Interleukin-15; D015375:Receptors, Interleukin-2 / Q000378:metabolism
D000911:Antibodies, Monoclonal; D019496:Cancer Vaccines; C508024:IL15RA protein, human; D019409:Interleukin-15; D007376:Interleukin-2; D053647:Receptors, Interleukin-15; D015375:Receptors, Interleukin-2